Css LLC Seres Therapeutics, Inc. Call Options Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $580,944 - $2.4 Million	-106,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $404,274 - $533,484	21,900 Added 25.92%	106,400 $2.54 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $695,804 - $1.14 Million	39,400 Added 87.36%	84,500 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $346,425 - $562,177	-14,900 Reduced 24.83%	45,100 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $224,400 - $1.72 Million	60,000 New	60,000 $1.7 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.